IGC Pharma Inc
IGC Pharma Inc (IGC) Implied Volatility Current
IGC implied volatility is 895%. IV Rank is 92%, placing current premiums in the top of their 52-week range.
Read more
Tracking IGC implied volatility helps you identify when options premiums on IGC Pharma Inc are historically cheap or expensive, and where the best trades are hiding. IGC Pharma Inc implied volatility reflects the market's expectation of future price movement: when IGC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor IGC Pharma Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IGC, tracking metrics like IGC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IGC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IGC implied volatility sits today versus where it has been. Our scanner ranks IGC Pharma Inc implied volatility against its historical range, surfaces extremes in IGC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether IGC Pharma Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is near its yearly peak - premiums are expensive, favoring sellers.
As of September 17, 2026
Trade options with IV on your side
Track IGC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→